Article
Astellas Pharma US, Inc. has announced that mirabegron (Myrbetriq), indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency, is now available through U.S. pharmacies.
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.